Turning Point Therapeutics, Inc. (TPTX) — Analyst outlook / Analyst consensus target is. Based on 14 analyst ratings, the consensus is bullish — 8 Buy, 6 Hold.
The consensus price target is $73.60, representing a downside of 2.5% from the current price $75.49.
TPTX Stock — 12-Month Price Forecast
$73.60
▼ -2.50% Downside
Average Price Target
Based on 14 Wall Street analysts offering 12-month price targets for Turning Point Therapeutics, Inc., the price target is $73.60.
The average price target represents a -2.50% change from the last price of $75.49.
TPTX Analyst Ratings
Buy
Based on 14 analysts giving stock ratings to Turning Point Therapeutics, Inc. in the past 3 months
